These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 26999915)
1. Update on Adolescent Immunizations. Schreier R; Halady T; Bishop N; Chatterjee A S D Med; 2016 Feb; 69(2):78-83. PubMed ID: 26999915 [TBL] [Abstract][Full Text] [Related]
2. Immunization update: pertussis, meningoccocus, and human papillomavirus. Middleman AB Adolesc Med Clin; 2006 Oct; 17(3):547-63; abstract ix-x. PubMed ID: 17030279 [TBL] [Abstract][Full Text] [Related]
3. Missed opportunities for adolescent vaccination, 2006-2011. Wong CA; Taylor JA; Wright JA; Opel DJ; Katzenellenbogen RA J Adolesc Health; 2013 Oct; 53(4):492-7. PubMed ID: 23809613 [TBL] [Abstract][Full Text] [Related]
4. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. America Academy of Pediatrics Commitee on Infectious Diseases Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131 [TBL] [Abstract][Full Text] [Related]
5. Adolescent Vaccination Performance in South Carolina Compared to the United States. Roberts JR; Naifeh M; Jacobson RM; Hinton E; O'Brien E; Rogacki B; Thompson D; Margolis B; Darden PM J S C Med Assoc; 2015 Dec-2016 Jan; 111(4):117-21. PubMed ID: 27141702 [TBL] [Abstract][Full Text] [Related]
6. Using the 4 Pillars™ Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination. Zimmerman RK; Raviotta JM; Nowalk MP; Moehling KK; Reis EC; Humiston SG; Lin CJ Vaccine; 2017 Oct; 35(45):6180-6186. PubMed ID: 28947346 [TBL] [Abstract][Full Text] [Related]
12. Patterns of Use of Human Papillomavirus and Other Adolescent Vaccines in the United States. Vielot NA; Butler AM; Brookhart MA; Becker-Dreps S; Smith JS J Adolesc Health; 2017 Sep; 61(3):281-287. PubMed ID: 28739327 [TBL] [Abstract][Full Text] [Related]
13. A population-level assessment of factors associated with uptake of adolescent-targeted vaccines in Michigan. Gowda C; Dong S; Potter RC; Dombkowski KJ; Dempsey AF J Adolesc Health; 2013 Oct; 53(4):498-505. PubMed ID: 24054080 [TBL] [Abstract][Full Text] [Related]
14. Simple and Elaborated Clinician Reminder Prompts for Human Papillomavirus Vaccination: AÂ Randomized Clinical Trial. Zimet G; Dixon BE; Xiao S; Tu W; Kulkarni A; Dugan T; Sheley M; Downs SM Acad Pediatr; 2018 Mar; 18(2S):S66-S71. PubMed ID: 29502640 [TBL] [Abstract][Full Text] [Related]
16. Coadministration of a 9-Valent Human Papillomavirus Vaccine With Meningococcal and Tdap Vaccines. Schilling A; Parra MM; Gutierrez M; Restrepo J; Ucros S; Herrera T; Engel E; Huicho L; Shew M; Maansson R; Caldwell N; Luxembourg A; Ter Meulen AS Pediatrics; 2015 Sep; 136(3):e563-72. PubMed ID: 26240207 [TBL] [Abstract][Full Text] [Related]
17. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years--United States, 2014. Reagan-Steiner S; Yankey D; Jeyarajah J; Elam-Evans LD; Singleton JA; Curtis CR; MacNeil J; Markowitz LE; Stokley S MMWR Morb Mortal Wkly Rep; 2015 Jul; 64(29):784-92. PubMed ID: 26225476 [TBL] [Abstract][Full Text] [Related]
19. National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(34):671-7. PubMed ID: 22932301 [TBL] [Abstract][Full Text] [Related]